Digital Digital therapeutics at a turning point: What we heard at DT... This year the digital therapeutics space took a hit with the downfall of Pear Therapeutics,
Views & Analysis Frontiers Health Steering Committee spotlight: Eugene Borukh... With Frontiers Health 2022 mere weeks away, we continue to interview members of the steering committee, gaining insight into what to expect from Milan.
Views & Analysis 7 questions: Bayer's Eugene Borukhovich Eugene Borukhovich's perspective on digital health and its future.
News Gene therapy firm Kate Tx snapped up by Novartis for $1.1bn Novartis buys gene therapy specialist Kate Therapeutics for $1.1 billion, adding an early-stage rival to Sarepta's muscular dystrophy therapy Elevidys
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends